Guidance: AI Airlock Phase 3 application

AI Airlock phase 3 call for applications

Candidates can now apply to the Medicines and Healthcare products Regulatory Agency (MHRA) to join the AI Airlock. Please submit applications using this portal – Application Portal

This application process is designed to gather information about candidates (including their AI enabled Medical Devices and prototypes, if they are a manufacturer) and evaluate their suitability for the AI Airlock sandbox.

The application window will remain open year-round, and applicants may submit an application at any time until this page is updated to indicate that the call has been closed. Applications will be evaluated in scheduled review waves and onboarded on a rolling basis. Applications submitted after a scheduled review will generally be carried forward to the next review wave.

The current priority regulatory challenge area is Post-Market Surveillance (PMS) and oversight across the lifecycle for AI enabled Medical Devices. Specific focus will be given to projects that address the priority topics set out below:

If you see a challenge area you are interested in exploring or addressing with the programme, and you have sufficient information to support hypothesis development and testing, please complete the relevant section of the form.

We are also open to expressions of interest from outside of these key focus areas. If there is a challenge you’d like to explore within the AI Airlock which does not fit into the PMS and lifecycle oversight challenge area, we would encourage you to submit your proposal using the form above and selecting the “Express interest in another regulatory focus area” option in the form.
These expressions will help to inform future priorities for the programme which we will update in due course, however, please note that priority will be given to proposals that align with current areas of focus.